---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-120663"
form_type: "8-K"
ticker: "TEM"
cik: "0001717115"
company_name: "Tempus AI, Inc."
filed_at: "2024-11-04T23:59:59+00:00"
generated_at: "2026-05-30T06:11:51.527062+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Tempus AI Q3 revenue $180.9M (+33% YoY), net loss $75.8M, agrees to buy Ambry Genetics for $600M

## Summary
- Q3 revenue $180.9M (+33% YoY); net loss $75.8M (incl. $22.2M stock comp); Adj EBITDA -$21.8M (improved $14.4M YoY).
- FY2024 guidance: revenue ~$700M (~32% growth), Adj EBITDA ~($105M), improvement of ~$50M over 2023.
- Acquired Ambry Genetics for $600M ($375M cash + $225M shares); Ambry expects >$300M rev, >$40M EBITDA in CY2024.
- Data & services rev +64.4% YoY, Insights rev +86.6%; Genomics unit growth 23.9%, rev +20.3%.
- Debt financing: $300M increase from Ares; cash & marketable securities $466.3M.

## SEC filing metadata
- accession: 0000950170-24-120663
- form_type: 8-K
- ticker: TEM
- cik: 0001717115
- company_name: Tempus AI, Inc.
- filed_at: 2024-11-04T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1717115/000095017024120663/0000950170-24-120663-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1717115/000095017024120663/tem-20241104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-120663
- JSON: https://secwatch.observer/filing/0000950170-24-120663.json
- Plain text: https://secwatch.observer/filing/0000950170-24-120663.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.